| 000 | 01460 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250517223243.0 | ||
| 264 | 0 | _c20181211 | |
| 008 | 201812s 0 0 eng d | ||
| 022 | _a1474-547X | ||
| 024 | 7 |
_a10.1016/S0140-6736(18)31184-X _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPatel, Tejas | |
| 245 | 0 | 0 |
_aEndpoints in diabetes cardiovascular outcome trials. _h[electronic resource] |
| 260 |
_bLancet (London, England) _c06 2018 |
||
| 300 |
_a2412 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Letter; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 |
_aCardiovascular Diseases _xmortality |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aEndpoint Determination |
| 650 | 0 | 4 |
_aHeart Failure _xepidemiology |
| 650 | 0 | 4 |
_aHospitalization _xstatistics & numerical data |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xadverse effects |
| 650 | 0 | 4 |
_aMyocardial Infarction _xepidemiology |
| 650 | 0 | 4 | _aOdds Ratio |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 |
_aStroke _xepidemiology |
| 700 | 1 | _aTesfaldet, Bereket | |
| 700 | 1 | _aChowdhury, Iffat | |
| 700 | 1 | _aKettermann, Anna | |
| 700 | 1 | _aSmith, James P | |
| 700 | 1 | _aPucino, Frank | |
| 700 | 1 | _aAlmario, Eileen E Navarro | |
| 773 | 0 |
_tLancet (London, England) _gvol. 391 _gno. 10138 _gp. 2412 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0140-6736(18)31184-X _zAvailable from publisher's website |
| 999 |
_c28543776 _d28543776 |
||